These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25746632)

  • 1. Treatment options for community-acquired pneumonia in the elderly people.
    Petrosillo N; Cataldo MA; Pea F
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):473-85. PubMed ID: 25746632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for community-acquired pneumonia in the elderly.
    Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
    Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of community-acquired pneumonia.
    File TM; Niederman MS
    Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the management of community-acquired pneumonia in the elderly patient.
    González-Castillo J; Martín-Sánchez FJ; Llinares P; Menéndez R; Mujal A; Navas E; Barberán J; ; ; ; ;
    Rev Esp Quimioter; 2014 Mar; 27(1):69-86. PubMed ID: 24676248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of community-acquired pneumonia in adults.
    Working Group of the South African Thoracic Society
    S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults.
    Hashemi SH; Soozanchi G; Jamal-Omidi S; Yousefi-Mashouf R; Mamani M; Seif-Rabiei MA
    Trop Doct; 2010 Apr; 40(2):89-91. PubMed ID: 20305102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in the elderly.
    Torres A; El-Ebiary M; Riquelme R; Ruiz M; Celis R
    Semin Respir Infect; 1999 Jun; 14(2):173-83. PubMed ID: 10391411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolones in the management of community-acquired pneumonia.
    Albertson TE; Dean NC; El Solh AA; Gotfried MH; Kaplan C; Niederman MS
    Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in the elderly.
    Fung HB; Monteagudo-Chu MO
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired pneumonia.
    Brown PD; Lerner SA
    Lancet; 1998 Oct; 352(9136):1295-302. PubMed ID: 9788476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New guidelines for the management of adult community-acquired pneumonia.
    Armitage K; Woodhead M
    Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.